These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6658)

  • 41. Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist.
    Hanson G; Alphs L; Pradhan S; Lovenberg W
    Neuropharmacology; 1981 Jun; 20(6):541-8. PubMed ID: 6165922
    [No Abstract]   [Full Text] [Related]  

  • 42. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra.
    Satoh H; Satoh Y; Notsu Y; Honda F
    Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
    Maggi A; Bruno F; Cattabeni F; Groppetti A; Parenti M; Racagni G
    Brain Res; 1978 Apr; 145(1):180-4. PubMed ID: 205324
    [No Abstract]   [Full Text] [Related]  

  • 44. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine.
    Barghon R; Costentin JH
    Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of dopaminergic and GABA-ergic interactions in seizure susceptibility.
    György L
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):280-6. PubMed ID: 526081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Behavioral activation by stimulation of a GABAergic mechanism in the preoptic area of rat.
    Osborne PG; Mataga N; Onoe H; Watanabe Y
    Neurosci Lett; 1993 Aug; 158(2):201-4. PubMed ID: 8233095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.
    Scheel-Krüger J
    Acta Neurol Scand Suppl; 1986; 107():1-54. PubMed ID: 3014800
    [No Abstract]   [Full Text] [Related]  

  • 48. Control of dopamine release by dopamine receptors and by impulse flow as studied by in vivo voltammetry.
    Gonon FG
    Ann N Y Acad Sci; 1986; 473():160-9. PubMed ID: 3492168
    [No Abstract]   [Full Text] [Related]  

  • 49. Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium.
    Gallager DW; Pert A; Bunney WE
    Nature; 1978 May; 273(5660):309-12. PubMed ID: 652037
    [No Abstract]   [Full Text] [Related]  

  • 50. Further evidence for a functional dorsal-ventral division of the rat striatum: GABAergic involvement in oral movements.
    Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M; Stephenson JD
    Eur J Pharmacol; 1993 Aug; 239(1-3):47-54. PubMed ID: 8223913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 52. GABA blockade, dopamine and schizophrenia: experimental studies in the cat.
    Stevens J; Wilson K; Foote W
    Psychopharmacologia; 1974; 39(2):105-19. PubMed ID: 4155802
    [No Abstract]   [Full Text] [Related]  

  • 53. Differential effects of striatal injections of dopaminergic, cholinergic and GABAergic drugs upon swimming behavior of rats.
    Vrijmoed-de Vries MC; Cools AR
    Brain Res; 1986 Jan; 364(1):77-90. PubMed ID: 3004649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-dopaminergic neurones of the reticular part of substantia nigra can gate static fusimotor action onto flexors in cat.
    Schwarz M; Sontag KH; Wand P
    J Physiol; 1984 Sep; 354():333-44. PubMed ID: 6090651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
    Biggio G; Corda MG; Casu M; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
    [No Abstract]   [Full Text] [Related]  

  • 56. Haloperidol and clazapine: specificity of action on GABA in the nigrostriatal system.
    Maggi A; Cattabeni F; Bruno F; Racagni G
    Brain Res; 1977 Sep; 133(2):382-5. PubMed ID: 902104
    [No Abstract]   [Full Text] [Related]  

  • 57. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that a nigral gabaergic--cholinergic balance controls posture.
    De Montis GM; Olianas MC; Serra G; Tagliamonte A; Scheel-Krüger J
    Eur J Pharmacol; 1979 Jan; 53(2):181-90. PubMed ID: 569589
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions between GABA, dopamine, acetylcholine, and glutamate-containing neurons in the extrapyramidal and limbic systems.
    Bartholini G; Scatton B; Worms P; Zivkovic B; Lloyd KG
    Adv Biochem Psychopharmacol; 1981; 30():119-28. PubMed ID: 6120626
    [No Abstract]   [Full Text] [Related]  

  • 60. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
    Bevan P
    Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.